We are live on ! Find out more
BL

Bleichroeder LP Portfolio holdings

AUM $579M
1-Year Est. Return 94.36%
This Fund
S&P 500
This Quarter Est. Return
+27.96%
1 Year Est. Return
+94.36%
3 Year Est. Return
+196.81%
5 Year Est. Return
+210.19%
10 Year Est. Return
–
AUM
$514M
AUM Growth
-$45.1M
Cap. Flow
-$126M
Cap. Flow %
-24.6%
Top 10 Hldgs %
70.54%
Holding
81
New
6
Increased
6
Reduced
6
Closed
9

Top Buys

1
BC icon
Brunswick
BC
+$13.7M
2
MRNS
Marinus Pharmaceuticals, Inc
MRNS
+$1.84M
3
HCARU
Healthcare Services Acquisition Corporation Unit
HCARU
+$1.54M
4
SONO icon
Sonos
SONO
+$1.21M
5
CRIS icon
Curis
CRIS
+$861K

Top Sells

1
RPRX icon
Royalty Pharma
RPRX
+$38.9M
2
XRX icon
Xerox
XRX
+$35.4M
3
DCP
DCP Midstream, LP
DCP
+$31.8M
4
AMAG
AMAG Pharmaceuticals
AMAG
+$12.2M
5
EOSE icon
Eos Energy Enterprises
EOSE
+$5M

Sector Composition

1 Healthcare 19.85%
2 Industrials 14.37%
3 Consumer Discretionary 11.57%
4 Materials 9.88%
5 Financials 6.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AMP icon
26
Ameriprise Financial
AMP
$48B
$3.11M 0.6%
15,993
– –
AXP icon
27
American Express
AXP
$244B
$3.02M 0.59%
25,000
– –
DISH
28
DELISTED
DISH Network Corp.
DISH
$2.51M 0.49%
77,500
– –
EPD icon
29
Enterprise Products Partners
EPD
$82.5B
$2.47M 0.48%
126,301
– –
CRIS icon
30
Curis
CRIS
$9.41M
$2.35M 0.46%
+717
New +$861K
IHC
31
DELISTED
Independence Holding Company
IHC
$2.24M 0.44%
54,711
– –
EOSEW
32
DELISTED
Eos Energy Enterprises Warrant
EOSEW
$2.08M 0.4%
250,000
– –
FLNA
33
Filana Therapeutics
FLNA
$51.7M
$1.94M 0.38%
284,314
-400,189
-58% -$3.57M
DUOT icon
34
Duos Technologies
DUOT
$261M
$1.92M 0.37%
453,616
– –
LBTYK icon
35
Liberty Global Class C
LBTYK
$3.47B
$1.65M 0.32%
69,618
– –
HCARU
36
DELISTED
Healthcare Services Acquisition Corporation Unit
HCARU
$1.53M 0.3%
+150,000
New +$1.54M
SONO icon
37
Sonos
SONO
$1.79B
$1.52M 0.3%
+65,000
New +$1.21M
PYPL icon
38
PayPal
PYPL
$49.5B
$1.17M 0.23%
5,000
– –
ORTX
39
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
$1.13M 0.22%
26,233
+1,233
+5% +$55.2K
BLUE
40
DELISTED
bluebird bio
BLUE
$1.08M 0.21%
1,930
– –
RIBT
41
DELISTED
RiceBran Technologies
RIBT
$1.04M 0.2%
170,333
– –
CUE icon
42
Cue Biopharma
CUE
$120M
$938K 0.18%
2,500
-2,500
-50% -$999K
VATE icon
43
INNOVATE Corp
VATE
$128M
$896K 0.17%
27,480
+20,326
+284% +$565K
LBTYA icon
44
Liberty Global Class A
LBTYA
$3.57B
$557K 0.11%
22,989
– –
INFI
45
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
$530K 0.1%
250,000
– –
BATRK icon
46
Atlanta Braves Holdings Series B
BATRK
$3.35B
$515K 0.1%
20,717
– –
ARKOW
47
DELISTED
ARKO Corp Warrant
ARKOW
$453K 0.09%
+333,333
New +$459K
RTX icon
48
RTX Corp
RTX
$266B
$429K 0.08%
6,000
– –
FGNA.WS
49
DELISTED
FG New America Acquisition Corp. Warrants, each whole warrant exercisable for one share of Class A c
FGNA.WS
$362K 0.07%
+250,000
New +$249K
LHX icon
50
L3Harris
LHX
$53.8B
$302K 0.06%
1,600
– –
1
2
3 4

Similar funds

BCM
Bourgeon Capital Management Darien, Connecticut $578M AUM 41.69% 1-Year Est. Return
LRIA
Leonard Rickey Investment Advisors Yakima, Washington $578M AUM 16.23% 1-Year Est. Return
WCCM
Webs Creek Capital Management Dallas, Texas $578M AUM 79.84% 1-Year Est. Return
MIOT
Massachusetts Institute of Technology Cambridge, Massachusetts $577M AUM 8.5% 1-Year Est. Return
AF
Aegis Financial Mc Lean, Virginia $580M AUM 105.74% 1-Year Est. Return
JCP
JB Capital Partners Armonk, New York $581M AUM 46.16% 1-Year Est. Return
GCM
Gibraltar Capital Management Tulsa, Oklahoma $581M AUM 18.65% 1-Year Est. Return
KNW
Kesler Norman & Wride Ogden, Utah $581M AUM 17.6% 1-Year Est. Return

Bleichroeder LP's Q4 2020 Portfolio in Review

As of Q4 2020, Bleichroeder LP held 81 positions worth $514M, down 8.1% from $559M the previous quarter. Its ten largest holdings account for 71% of the portfolio.

Bleichroeder LP withdrew a net $126M in Q4 2020, closing 9 positions and reducing 6 holdings. Its most notable exit was DCP Midstream, LP, an estimated $31.8M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 23% a quarter earlier, followed by Industrials and Consumer Discretionary.

Against the trend, Bleichroeder LP opened a new position in Healthcare Services Acquisition Corporation Unit worth $1.53M.

  • Bleichroeder LP's largest Q4 2020 buy was Healthcare Services Acquisition Corporation Unit: 150,000 shares worth $1.53M.
  • Bleichroeder LP added most to Brunswick in Q4 2020, an estimated $13.7M increase.
  • Bleichroeder LP's biggest Q4 2020 reduction was Royalty Pharma, cutting an estimated $38.9M.
  • Bleichroeder LP fully exited DCP Midstream, LP in Q4 2020, selling an estimated $31.8M.
  • Bleichroeder LP's ten largest holdings make up 71% of its $514M portfolio in Q4 2020.
  • Bleichroeder LP opened 6 new positions and closed 9 in Q4 2020.
  • Bleichroeder LP's portfolio value fell 8.1% quarter-over-quarter to $514M.

Based on Bleichroeder LP's 13F filing for Q4 2020, filed 10 Feb 2021.